| |
| |
|
| Insider
Information: |
Camardo Daniel A. |
| Relationship: |
CEO, Director |
| City: |
Dublin |
| State: |
L2 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
318,241 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$932,297 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
318,241 |
|
|
| Total
Value |
$932,297 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Horizon Pharma, Inc. |
HZNP |
EVP and President, U.S. |
2021-03-30 |
32,900 |
|
0 |
Premium* |
|
|
Athersys Inc (New) |
ATHX |
CEO, Director |
2023-10-04 |
285,341 |
2022-03-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATHX |
Athersys Inc (New) |
CEO |
• • – |
2023-10-04 |
4 |
D |
$0.44 |
$8,797 |
D/D |
(19,993) |
285,341 |
0 |
- |
|
| ATHX |
Athersys Inc (New) |
CEO |
• • – |
2023-07-05 |
4 |
D |
$0.91 |
$18,274 |
D/D |
(19,993) |
305,334 |
0 |
- |
|
| ATHX |
Athersys Inc (New) |
CEO |
• • – |
2023-04-04 |
4 |
D |
$1.00 |
$19,993 |
D/D |
(19,993) |
325,327 |
0 |
- |
|
| ATHX |
Athersys Inc (New) |
CEO |
• • – |
2022-11-22 |
4 |
B |
$0.55 |
$54,960 |
D/D |
100,000 |
368,804 |
2.81 |
% |
|
| ATHX |
Athersys Inc (New) |
Chief Executive Officer |
• • – |
2022-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
263,492 |
268,804 |
0 |
- |
|
| ATHX |
Athersys Inc (New) |
CEO |
• • – |
2022-03-17 |
4 |
B |
$0.77 |
$102,256 |
D/D |
132,800 |
132,800 |
2.81 |
% |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and President, U.S. |
• – – |
2021-03-30 |
4 |
AS |
$83.58 |
$1,103,006 |
D/D |
(12,900) |
32,900 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and President, U.S. |
• – – |
2021-02-21 |
4 |
D |
$88.87 |
$51,189 |
D/D |
(576) |
45,800 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and President, U.S. |
• – – |
2021-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,300 |
46,376 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and President, U.S. |
• – – |
2021-01-21 |
4 |
D |
$77.43 |
$110,493 |
D/D |
(1,427) |
45,076 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and President, U.S. |
• – – |
2021-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,220 |
46,503 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and President, U.S. |
• – – |
2021-01-05 |
4 |
D |
$73.28 |
$676,374 |
D/D |
(9,230) |
43,283 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and President, U.S. |
• – – |
2021-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,614 |
52,513 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and President, U.S. |
• – – |
2020-11-06 |
4 |
S |
$76.76 |
$268,663 |
D/D |
(3,500) |
30,829 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and President, U.S. |
• – – |
2020-10-01 |
4 |
D |
$80.42 |
$358,673 |
D/D |
(4,460) |
34,329 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and President, U.S. |
• – – |
2020-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
38,789 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and President, U.S.Officer |
• – – |
2020-07-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,789 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
